Illumina, Inc. - Common Stock (NQ:ILMN)

273.04 +7.32 (+2.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

39 40 Next >

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

Illumina Announces Long-Term Strategic Partnership with Janssen

May 02, 2022

SOURCE: Illumina

Via 3BL Media

How Collaboration Is Driving the Next Wave of Genomics

April 29, 2022

SOURCE: Illumina

Via 3BL Media

Analyst Ratings For Illumina ↗

March 29, 2022

Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter:

Via Benzinga

A Promising Industry 4.0 Breakthrough in the Biochip Market, Award-Winning Automated Optical Inspection System Powered by Taiwan Tech

April 27, 2022

About SparkAmplify Distribution SparkAmplify was founded in 2016. It is a SaaS company based in California and Taipei, specializing in media outreach and influencer engagement. The team consists of a...

Via PRUnderground

Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

April 27, 2022

SOURCE: Illumina

Via 3BL Media

Markets Pare Early Losses As Musk-Twitter Agree On Buyout Deal ↗

April 25, 2022

U.S. indices pared early losses and closed higher Monday. Markets were trading lower to start the session as stocks continued to fall after the Fed last week indicated it may move...

Via Benzinga

FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis ↗

April 20, 2022

The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was...

Via Benzinga

Illumina Singapore Receives Best Employer Award for Third Time

April 19, 2022

SOURCE: Illumina

Via 3BL Media

Illumina's Chief Financial Officer, Sam Samad, Selected As a San Diego Business Journal 2022 CFO of the Year

April 18, 2022

SOURCE: Illumina

Via 3BL Media

Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers ↗

April 16, 2022

Let’s pause to consider earlier attempts at hostile takeovers by well-respected and well-financed entities and individuals that — to ransack some Musk-worthy clichés — took off like a rocket ship but...

Via Talk Markets

Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers ↗

April 15, 2022

As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover.

Via Benzinga

Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center

April 13, 2022

SOURCE: Illumina

Via 3BL Media

John Frank Joins Illumina as Chief Public Affairs Officer

April 12, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Releases Annual Corporate Social Responsibility Report

April 07, 2022

SOURCE: Illumina

Via 3BL Media

Here's How Much You Would Have Made Owning Illumina Stock In The Last 5 Years ↗

April 06, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 1.75% on an annualized basis producing an average annual return of 15.45%. Currently, Illumina has a market capitalization of...

Via Benzinga

3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard ↗

April 01, 2022

Medical and gold stocks led the S&P 500. Transport stocks were big losers.

Via Investor's Business Daily

DNA Data Storage Alliance Welcomes 50th Member

April 05, 2022

From DNA Data Storage Alliance

Via Business Wire

April Fool ↗

April 01, 2022

Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022 ↗

March 29, 2022

Upgrades

Via Benzinga

Join Illumina on World Tuberculosis Day to Raise Awareness and Keep the Fight Up to Eradicate TB

March 24, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Celebrates Shannon Whitmore: A Real Time Revolutionary and Scientific Computing Innovator

March 22, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications

March 18, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

March 16, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients ↗

March 15, 2022

Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the...

Via Benzinga

Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India

March 15, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Named One of Fast Company's Most Innovative Companies for 2022

March 09, 2022

SOURCE: Illumina

Via 3BL Media

Celebrating Women's History Month: Illumina Spotlights Scientist Geraldine Pittman Woods

March 08, 2022

SOURCE: Illumina

Via 3BL Media

Illumina's Technology Supports Biodiversity and Conservation Initiatives

March 04, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Celebrates Rare Disease Day

March 01, 2022

SOURCE: Illumina

Via 3BL Media

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.